Monthly Communication Report

Corporation:	Eli Lilly Canada Inc.
Associated registration:	954779-6034-33
Communication date:	2024-02-26
Posted date:	2024-03-15

Designated Public Office Holders who participated in the communication:	Erin Campbell, Director Innovation, Science and Economic Development Canada (ISED) Michelle Ciesielski, Manager, Office of Patented Medicines and Liaison Health Canada (HC) David Lee, Chief Regulatory Officer Health Canada (HC) Anne Bowes, Director Health Canada (HC) Paul Brogan, Market Director Invest in Canada Hub
Subject Matter of the communication:	Health
Responsible Officer who filed this communication report:	Kenneth L Custer
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.